Gongwin Biopharm Holdings Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced total revenue was TWD 62,000 compared to TWD 1.053 million a year ago. Operating loss was TWD 123.850 million compared to TWD 138.056 million a year ago. Net loss was TWD 110.747 million compared to TWD 123.789 million a year ago. Basic loss per share was TWD 1.1 compared to TWD 1.27 a year ago.